Immunogenicity and Safety of Sequential 2vHPV-9vHPV Vaccination in Girls Aged 9-14 Years
NCT07281677
·
clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
400
Enrollment
OTHER_GOV
Sponsor class
Conditions
HPV Infection
Interventions
BIOLOGICAL:
bivalent HPV vaccine
BIOLOGICAL:
9-valent HPV vaccine
Sponsor
Zhejiang Provincial Center for Disease Control and Prevention